GHRH Receptor Pharmacology
Studied in experimental systems examining interaction with the growth hormone-releasing hormone receptor and associated receptor activity.
UK StockedReady to ship
Same-Day DispatchOrders placed before 2pm
Free Tracked 24On orders over £25
Compound overview
10mg lyophilised Tesamorelin for laboratory research.
At a glance
Compound type Single-peptide research compound
Vial content 10MG
Format Lyophilised powder
Testing Third-party HPLC
Research focus
Receptor-Mediated Signalling
Investigated in models examining intracellular signalling mechanisms following GHRHR activation.
Endocrine Signalling Models
Used in experimental research involving peptide-mediated endocrine communication and regulatory signalling pathways.
Downstream Cellular Responses
Examined in relation to biochemical and cellular responses associated with GHRH receptor signalling.
Key features
- 10mg Tesamorelin per vial
- ≥98% purity
- Third-party tested
- Synthetic GHRH analogue
- Stable lyophilised format
- UK stocked and dispatched
- Suitable for controlled in vitro research
View full research overview
Tesamorelin 10mg is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) used in experimental research examining GHRH receptor pharmacology, peptide-mediated endocrine signalling, and downstream cellular response pathways.
Each vial contains 10mg of Tesamorelin supplied as a lyophilised powder for controlled in vitro laboratory and scientific research.
Tesamorelin is investigated for its interaction with the GHRH receptor (GHRHR) and associated intracellular signalling mechanisms. These characteristics make it useful in experimental systems examining receptor activation, peptide–receptor interactions, endocrine signalling pathways, and related biochemical responses.
Key Features
- 10mg Tesamorelin per vial
- ≥98% purity
- Third-party tested
- Synthetic GHRH analogue
- Stable lyophilised format
- UK stocked and dispatched
- Suitable for controlled in vitro research
Area of Interest
Laboratory research involving Tesamorelin has examined several receptor and signalling pathways:
- GHRH Receptor Pharmacology: Studied in experimental systems examining interaction with the growth hormone-releasing hormone receptor and associated receptor activity.
- Receptor-Mediated Signalling: Investigated in models examining intracellular signalling mechanisms following GHRHR activation.
- Endocrine Signalling Models: Used in experimental research involving peptide-mediated endocrine communication and regulatory signalling pathways.
- Downstream Cellular Responses: Examined in relation to biochemical and cellular responses associated with GHRH receptor signalling.
- Peptide Structure–Activity Research: Studied as a synthetic GHRH analogue in research examining relationships between peptide structure, receptor interaction, and signalling activity.
Together, these areas make Tesamorelin a peptide of interest for in vitro research into GHRH receptor pharmacology, peptide–receptor interactions, endocrine signalling, and associated cellular response mechanisms.
For in vitro laboratory research only. Not for human or veterinary use.
Compound: Tesamorelin
Strength: 10mg
Format: Lyophilised powder
Purity: ≥98%
Testing: Third-party tested
Intended Use: Laboratory research only
Human Use: Not intended for human consumption or administration
Storage
Store refrigerated at 2–8°C. For long-term storage, store frozen at −20°C. Keep sealed and protected from light and moisture..
⚠ For in vitro laboratory research only. Not for human or veterinary use.
TESAMORELIN
10MG
10mg lyophilised Tesamorelin for laboratory research.
£59.95
Calculating dispatch time...
In Stock · UK dispatch
For in vitro laboratory research only. Not for human or veterinary use.
Third-party tested Free Tracked 24 over £25 Secure checkout
